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1. Introduction  
Periodontitis is a generally chronic disorder characterized by the breakdown of the tooth-
supporting tissues and the impaired host inflammatory immune response. This condition is 
due fundamentally to an ecological imbalance between the normal microbial biofilm on 
teeth and the host tissues. There is increasing evidence linking periodontitis to systemic 
diseases, such as diabetes, rheumatoid arthritis, and, especially, CVD, hence the search for 
factors that may explain such relationships. A potential factor which could increase insulin 
resistance is the production of oxidative stress enhancing ROS in affected periodontal 
tissues (Bullon et al, 2009). 
Metabolic syndrome as originally described is a combination of obesity, hypertension, 
impaired glucose tolerance or diabetes, hyperinsulinemia, and dyslipidemia (elevated 
triglycerides and decreased high-density lipoprotein-cholesterol [HDL-C] levels). These 
same features are also considered as risk factors for atherosclerosis, therefore leading to the 
deduction that metabolic syndrome constitutes a risk for coronary heart disease. In spite of 
extensive clinical research on metabolic syndrome, relatively little attention has been 
directed to its possible relationship to periodontitis. The available data come from 
epidemiological studies. In a group of 1315 affected individuals (30-92 yrs old), the 
prevalence of metabolic syndrome was higher among individuals with advanced 
periodontitis (66.7%) than in periodontally healthy individuals (48.8%) (Borges et al., 2007). 
Analysis of data from 13,710 participants in the NHANES III (Third National Health and 
Nutrition Examination Survey) showed a direct relationship between periodontitis and the 
prevalence of metabolic syndrome (37% in those with severe periodontitis vs. 18% in those 
with mild or no periodontitis), and, particularly, higher prevalence of obesity (48-54% vs. 
31%), hypertension (51-56% vs. 27%), and high glucose levels (18-24% vs. 8%) were stated to 
be in the moderate to severe periodontitis group compared with the mild periodontitis or 
periodontally healthy group (D’Aiuto et al., 2008).  
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On the other hand, impaired glucose regulation disorders different from diabetes have been 
considered in periodontal research, and some encouraging findings have been obtained. 
Therefore, having deep pockets is significantly associated with impaired glucose tolerance 
in Japanese non-diabetic subjects and other study in an Israeli non-diabetic adult population 
revealed a higher occurrence of alveolar bone loss in subjects with elevated fasting glucose 
level of ≥ 100 mg/dL (Zadik et al, 2010). 
A group of 5,632 participants in the Atherosclerosis Risk in Communities Study were 
examined in order to establish any relationship between periodontal status, interleukin 1-
beta (IL-1ǃ) levels in gingival crevicular fluid (GFC) and HOMA-IR index (Sutherland et al, 
2002). An association between periodontal status and the 90th percentile of HOMA-IR was 
demonstrated, whenever coexisting high GCF IL-1ǃ levels were present. This is an 
important finding, as IL-1ǃ is related to the pathogenesis of insulin resistance, as well as 
tumor necrosis factor alpha (TNF-ǂ) (Tilg and Moschen, 2008). Our study supports that a 
putative relationship between insulin resistance and periodontitis exists. When studied 
separately, diet can be related to both insulin resistance and periodontitis, nonetheless, we 
found out that dietary intake seems not to be a determining factor for insulin resistance 
when it is associated with periodontal disease (Granados-Principal et al, 2011). 
Finally, in periodontitis, some perturbation in lipid biomarkers, for example increased total 
cholesterol in serum and lowdensity lipoprotein cholesterol, has been established. Thus, 
severe periodontitis is associated with a modest decrease in HDL and LDL cholesterol, and a 
more robust increase in plasma triacylglycerols. Intensive periodontal therapy results in 
reductions of total and LDL systemic cholesterols. Nevertheless, the relationship between 
fatty acids and periodontitis has been demonstrated in only a few studies. Some of these 
show that n-3 PUFA dietary supplementation modulates alveolar bone resorption following 
Porphyromonas gingivalis infection in rats and reduces the gingival tissue levels of 
prostaglandin E2, platelet-activation factor, and leukotriene B4, this being a useful adjunct in 
the treatment of CP. On the contrary, periodontitis patients with bone loss showed a higher 
n-6 PUFA plasma level than 27 control subjects. To clarify the situation, we investigated the 
potential linkage between periodontitis and plasma fatty acids profile, an established 
cardiovascular disease (CVD) risk factor. Our group has recently demonstrated in 35 years 
old patients that there is an inter-relationship between periodontitis, plasma fatty acids 
profile and the increase in metabolic risk factors for cardiovascular diseases (Ramirez-
Tortosa et al, 2010). In that paper, the authors found that total plasma fatty acids, saturated, 
n-6 polyunsaturated and monounsaturated fatty acids, peroxidability index, soluble VCAM, 
TNF-ǂ, cholesterol, triacylglycerols, and VLDL-c were significantly higher in the 
periodontitis group compared to the non-periodontitis group. The close association found 
between plasma triacylglycerols, LDL-c, saturated fatty acids, polyunsaturated fatty acids, 
total amount of fatty acids and coenzyme Q10 with some periodontal data such as 
periodontal probing depth, recession of the gingival margin and clinical attachment level 
(Pearson correlation between 0.3 and 0.6), leads to the conclusion that there is an inter-
relationship between periodontitis, plasma fatty acids profile and the increase in metabolic 
risk factors for cardiovascular diseases. 
Taking in account all above mentioned the aim of this chapter is to describe the 
cardiovascular risk factors related with periodontal disease and their relationship because 
perhaps an interaction between both diseases may result in a worse evolution of them. 
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2. Periodontitis 
2.1 Introduction 
Tooth structure consists of two different parts: crown, covered with enamel and root, under 
the gingival line.  Dentin comprises most of the tooth parenchyma, and surrounds the pulp 
chamber, where there are lots of blood vessels and nerves. 
Tooth is anchored firmly in the alveolus by the periodontium, a structure that is formed by 
gums, alveolar bone, tooth cementum and periodontal ligament. The periodontal ligament 
fixes the tooth concrete to the alveolar bone. Above the ligament, there is a gum fringe, just 
under the crown. Over the crown base; there is a few millimeters (1 to 3 mm) gap of gum 
that forms a superficial groove, in the border between the gum and the tooth.  
Periodontitis is an inflammation and infection of bones and ligaments that act as holders of 
teeth. It appears when inflammation and infection of gums (gingivitis) is left without 
treatment or when this treatment is delayed so much time. This inflammation and infection 
disseminate from gums to ligaments and bones that holds teeth. Due to this loss of support, 
teeth finally fall out. This problem is infrequent in children, but it’s the first cause of dental 
loss in adults and it affects between 10 % – 15 % of the world population (Baelum & Lopez, 
2004). 
Dental plaque and tartar accumulates on the basis of teeth. It can be prevented by adequate 
tooth cleaning methods and periodic cares from a professional.  This inflammation makes 
that between the gum and teeth, cumulus of tartar and dental plaque are deposited. 
Continuous inflammation finally develops destruction of tissue and bones surrounding the 
teeth. Because dental plaque contains germs, it is probably to develop dental abscess, which 
also contributes to bone destruction. Microorganism at dental plaque releases inflammatory 
substances that provoke an inflammatory response by immune cells from the host. 
Leukocytes, mainly neutrophils are recruited by chemotactic stimuli, and they phagocyte 
and digest this bacteria, preventing them from releasing more inflammatory cytokines. 
Although this will prevent gingivitis to appear, when neutrophils are overloaded by an 
excess of bacteria, they degranulate, releasing lots of enzymes and cytokines, aggravating 
the inflammation and the gingivitis (Kinane, 2001). 
It is to say that not all gingivitis progresses to periodontitis and that it does not have to affect 
every teeth at the same time. Not all periodontitis progress equally in each person, some are 
more resistant to the development of periodontitis and some are more given to it. Only a 
few people suffer from advanced tissue destruction around the teeth due to periodontitis 
and this disease passes with brief episodes of exacerbation and occasional remission. Most 
people who develop clinical signs of gingivitis do it after 10 – 20 days of plaque 
accumulation. It appears as redness, swelling and an increased tendency of the gingiva to 
bleed on gentle probing and it is still reversible to a normal status if the plaque is effectively 
removed. Periodontitis appears around 6 months before the establishment of gingivitis, but 
it depends on every single patient (Brecx et al, 1988). 
There are several factors that modify the possibility of suffering periodontitis, besides a lack 
of dental care, such as smoking, drugs (calcium blockers as nifedipine, phenytoin or 
cyclosporines) hormonal status, stress, age, socioeconomic status and race, systemic 
diseases, genetics or individual immune response. 
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2.2 Immune response by host cells and inflammation 
Inflammation at the periodontium begins when both bacteria and leukocytes start their fight 
releasing lots of pro inflammatory factors. The immune response is generated by cell wall 
components from the bacteria, including lipopolysaccharide (LPS) (Monteiro et al, 2009). 
Bacteria from the periodontium and some of its components are able to even reach other 
parts of the organism and produce an inflammatory response there (Tonetti, 2009). 
It is now known some of those molecules implicated in the connective tissue destruction, 
although there are many pathways that correlates between them and participate in this 
process and we don´t know exactly which paper plays every molecule, but the most 
important involved players are: connective tissue metalloproteinases, reactive oxygen 
species (ROS) and phagocytosis of matrix components. 
Matrix metalloproteinase activity is controlled in vivo through four separate mechanisms: 
First, they need to be activated by plasmin, trypsin or other proteinases. Second, interleukin-
1 (IL-1) and transforming growth factor-ǃ (TGF-ǃ), induced in inflamed tissues, regulates 
metalloproteinase production. Third, an ǂ2-macroglobulin serum inhibitor is able to 
inactivate matrix metalloproteinases and fourth, there is a group of protein inhibitors of 
matrix metalloproteinases (TIMP) that prevent the conversion of precursor forms of matrix 
metalloproteinases to their active forms. 
Immune response to periodontitis is the key that opens the door to an oxidative stress status 
and ROS production in the host. Neutrophils are the first line of defense against this 
infection and one way to achieve their goal is through ROS and reactive nitrogen species 
(RNS) production by nicotinamide adenine dinucleotide phosphate-oxidase (NADPH 
oxidase) and nitric oxide synthase (NOS) respectively. Neutrophil NADPH oxidase is a 
proteic complex normally dissociated until stimulation by protein kinase C (PKC), which 
phosphorylate p47-phox, a protein that facilitates assembly of NADPH oxidase subunits. 
PKC is also activated by sn-1, 2-diacylglycerol (DAG). ROS produced then can also act as 
second messengers activating other pathways, included inflammation, immune response, 
cell proliferation or apoptosis (Fialkow et al, 2007). 
T-cells and B-cells are involved in the defense against periodontitis. Their release products 
have been detected at the inflammation sites, such as interleukin-2 (IL-2), interleukin-12 (IL-
12), tumor necrosis factor-ǂ (TNF-ǂ) and interferon-Ǆ from lymphocyte T helper 1 (Th1); 
interleukin-4 (IL-4), interleukin-5 (IL-5), interleukin-6 (IL-6), interleukin-10 (IL-10) and 
interleukin-13 (IL-13) from lymphocyte T helper 2 (Th2) and TGF-ǃ from lymphocyte T 
helper 3 (Th3). T-cells prevail in early stages of the disease while B-cells do it at later stages 
of periodontitis. It is thought to be a switch between them as the disease gets worse. There is 
also a great production of immunoglobulin G (IgG) and Immunoglobulin A (IgA) from B-
cells (Kiane et al, 2007). 
Other cells as macrophages, mononuclear antigen presenting cells, dendritic cells, 
endothelial cells or adipocytes participate in immune response. These cells possess surface 
receptors that recognize harmful molecules. Macrophages present a toll-like receptor that 
recognize lipopolysaccharide (toll-like receptor-4) produced by bacteria in periodontitis, and 
advanced glycation end products receptor (RAGE) for recognition of advanced glycation 
end products (AGEs) produced in diabetes. These receptors are able to activate nuclear 
factor kappa-beta (NF-κǃ) pathway that promote the expression of inflammatory cytokines 
(Nassar et al, 2007). 
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NF- κǃ pathway modulates a wide variety of gene expressions, but we are interested mostly 
in its capacity of modulating interleukin-8 (IL-8) expression, which regulates neutrophil 
migration. Activation of NF- κǃ pathway will be an important contributor to inflammation 
whereas it is activated. TNF-ǂ is one of the main activators of this pathway. If TNF-ǂ is 
released, it is surely to have an enhanced NF- κǃ pathway activation. Also IL-1ǃ is able to 
activate NF- κǃ pathway but in a lesser degree than TNF-ǂ (Fitzgerald et al, 2007). 
2.3 Periodontitis and ROS 
ROS are chemically reactive molecules derived from oxygen that can damage lipids, 
proteins and DNA. They can also act as cell signaling molecules. ROS are produced every 
time at every single moment in every aerobic organism by the respiratory electron transport 
chain at the mitochondria, p450 cytochrome reactions, peroxisomal fatty acid metabolism 
and NADPH oxidase activity, but, normally, there is a balance between ROS and 
antioxidant molecules. It is when this balance is broken when ROS begin their harmful 
activity and an oxidative stress situation is established (Borges et al, 2007). 
In mild and chronic periodontitis, ROS generation is enhanced and plasma antioxidant levels 
are depleted. This ROS generation at the site of periodontitis can also have systemic effects on 
other organs as ROS can diffuse into the blood stream and reach other places on the organism. 
This is specially worth investigating on it, because it is known that serious diseases as 
cardiovascular disease and diabetes are related with ROS generation at the organism. 
People suffering from chronic periodontitis have higher C reactive protein (CRP) plasma 
levels. This is a powerful pro inflammatory molecule that also participates in other 
pathologies as obesity (D’Aiuto et al, 2010) and it is a good marker of the development of 
atherosclerosis and myocardial infarction (Tonetti, 2009). 
As It has mentioned before, periodontitis appears as the result of all the cytokines, ROS and 
inflammatory molecules released from the microorganisms and the host immune cells at the 
site of the inflammation at the teeth. The presence of a high amount of neutrophils, as this is 
the main host response to bacterial invasions, give us the idea of the great amount of ROS 
that can be released from them to combat the infection. There is also systemic inflammation 
in periodontitis as assessed in some studies measuring plasma CRP (Paraskevas et al, 2008), 
which can influence the production or ROS all over the organism. 
The most important ROS involved in periodontitis are: 
Hydroxyl radical (*OH), very active in damaging DNA proteins and lipids. It is able to 
initiate the lipid peroxidation chain, leading to vasodilation and bone reabsorption. Its 
molecular mechanism of action is by stimulation of the NF-K B-IKB complex, activating then 
NK-κB, which helps nuclear translocation and downstream of proinflammatory cytokines as 
IL-2, IL-6, IL-8, ǃ-interferon and TNF-ǂ (Borges et al, 2007). 
Hydrogen peroxide (H2O2), capable of crossing the nuclear membrane and damaging the 
DNA. DNA damage is measured by quantifying levels of 8-hydroxydeoxyguanosine (8-
OHDG), that is increased in periodontal tissues in periodontitis (Ekundi et al, 2010). 
Superoxide anion (O2*-), involved in bone reabsorption as many studies have corroborated 
by measuring the presence of this anion near the sites of bone reabsorption. 
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The most important cellular antioxidants are the enzymes superoxide dismutase (SOD), 
catalase, and glutathione peroxidase, glutathione-S transferases and aldehyde 
dehydrogenases. There are also non enzymatic antioxidants as carotenoids, vitamin E, C, 
coenzyme Q10, ǂ-lipoic acid, antioxidant minerals (selenium, zinc, copper, manganese), 
phenols, flavonoids, lycopene or hydroxytyrosol. When levels of these enzymes are 
lowered, the organism is unable to neutralize ROS and they can exert its harmful effect 
(Vicents & Taylor, 2006). 
So, ROS are involved both in tissue destruction in periodontitis and in systemic 
inflammation. They are also involved in several systemic diseases as metabolic syndrome, 
diabetes, obesity or cardiovascular disease. This means that it can be a link between 
periodontitis and these diseases, which altogether are risk factors for cardiovascular disease. 
We are going to inquire in the relation of ROS, oxidative stress and these diseases to 
understand why the generation of ROS in periodontitis can be linked to the apparition or 
deterioration of these diseases that in the end lead to cardiovascular disease. 
ROS sources
 Mitochondrial electron transport chain
 P450 cytochrome
 Peroxisomal fatty acid metabolism
 NADPH oxidase
 Xanthine oxidase
 Lipoxygenase
 Uncoupled NOS
 Myeloperoxidase
 Host immune cells
 
Fig. 1. ROS sources. 
3. Cardiovascular disease 
Cardiovascular diseases are the world’s largest killers, claiming 17.1 million lives a year, 
representing 29% of all global deaths. Cardiovascular diseases (CVDs) are a group of 
disorders of the heart and blood vessels and include: 
 Coronary heart disease 
 Cerebrovascular disease 
 Peripheral arterial disease 
 Rheumatic heart disease 
 Congenital heart disease 
 Deep vein thrombosis and pulmonary embolism 
Heart attacks and strokes are usually acute events and are mainly caused by a blockage that 
prevents blood from flowing to the heart or brain. The most common reason for this is a 
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build-up of fatty deposits on the inner walls of the blood vessels that supply the heart or 
brain. Strokes can also be caused by bleeding from a blood vessel in the brain or from blood 
clots. 
3.1 Cardiovascular disease and ROS 
Although hypertension is the main cause for having a cardiovascular event, ROS can also 
affect and damage cardiac tissues directly, leaving heart more susceptible to any other 
damage. Sources of ROS in cardiac tissue are not already unknown for us. These sources are 
the mitochondrial respiratory chain, NADPH oxidases, xanthine oxidases, lipoxygenase, 
uncoupled NOS and myeloperoxidase. There are evidences that ROS production by these 
systems are involved in cardiac damage and the apparition of heart failure diseases as 
congestive heart failure, angiotensin II dependent cardiac hypertrophy or cardiac fibrosis 
,inter alia. 
It is known that ROS can harm cardiac tissue because after reperfusion injury, there is a 
great increase in ROS production, attributed to an overload of all the ROS sources 
mentioned above and to a high infiltration of neutrophils that release pro inflammatory 
citokynes. This will damage myocytes, impair contractile function and contribute to 
capillary leakage (Chang et al, 2010). 
3.2 Cardiovascular disease and periodontitis  
Nowadays, there are several studies linking periodontitis with cardiovascular diseases 
(Paquette et al, 2007). We have seen how periodontitis can lead to an oxidative stress status 
in the organisms that will promote the onset of other diseases as obesity, diabetes or 
hypertension that are risk factors for cardiovascular disease and the possible mechanisms of 
how this happens. There is also evidence of direct damage by ROS to cardiac tissue and 
even DNA from periodontal pathogens in atheroma plaques, suggesting that they can also 
spread from the periodontium and travel throughout the blood stream (Tonetti, 2009). But 
there is another one important fact about how periodontitis can affect cardiovascular health, 
and it is the formation of the atheroma plaque or atherosclerosis. 
Atherosclerosis begins with stimuli from LDL or pro inflammatory proteins to endothelial 
cells which will express adhesion factors, chemokines and growth factors that attract 
monocytes from circulating blood. These monocytes can enter the intima and differentiate 
into macrophages. Macrophages then are able to uptake oxidized LDL and cholesterol and 
they transform in foam cells, damaging the intima. Then, activation of T lymphocytes, 
smooth muscle cells proliferation and migration and extracellular matrix deposition interact 
with molecules in the intima, promoting necrosis and forming fibrous plaques. These 
plaques are atheroma plaques and will grow and enlarge. Consequences of this could be 
occlusion of the artery where the atheroma plaque is formed or rupture of the plaque, 
releasing a plaque fragment that may be transformed into a thrombus that can obstruct 
blood flow anywhere on the body, with the risk of producing an acute cardiovascular event 
or stroke (Chang et al, 2010). ROS periodontitis production could be dangerous due to the 
oxidation of LDL and its pro atherogenic role. People with periodontitis have higher levels 
of plasma oxidized LDL levels, which means higher risk of developing atheroma plaque. 
Treatments directed to improve periodontitis achieved a lowering in oxidized LDL plasma 
www.intechopen.com
 
Cardiovascular Risk Factors 
 
200 
levels (Tamaki et al, 2010). Platelets also contribute greatly to atheroma plaque formation. It 
is known that platelet activation is increased in people suffering from periodontitis, being 
greater this activation as periodontitis severity increases (Papapanagiotou et al, 2009). 
Furthermore, platelets are able to bind fibrinogen and form thrombi that can occlude any 
blood vessel by themselves without the need of an atheroma plaque. The reason of this 
platelet activation could be in the action of periodontitis associated bacteria. It is to say that 
platelets are activated by the vasodilator–stimulated phosphoprotein (VASP) whose mission 
is to regulate platelet activation. When phosphorylated, VASP inhibit platelet activation, but 
in periodontitis, there is a decrease in VASP phosphorylation due to direct interaction 
between these periodontitis associated bacteria and VASP, leading to higher platelet 
activation (Laky et al, 2011). 
But atherogenesis is not the only risk factor involved in cardiovascular events. Mitochondria 
play an important part in heart damage. Mitochondria are the primary source of 
intracellular ROS. When damaged, mitochondria suffer a dysfunction in their activity 
making them to produce huge amounts of ROS and release pro apoptotic proteins into the 
cytosol that can trigger apoptosis in the cell. ROS are able to slowly damage mitochondria 
but the key is the damage to mitochondrial DNA (mtDNA) that is produced when, because 
of punctual mutations in mtDNA due to ROS action, mitochondria is unable to properly 
work and begins producing high amounts of ROS and these pro apoptotic proteins as 
cytochrome c or apoptosis inducing factor (AIF) that destroy the cell. People suffering from 
atherosclerosis have higher mtDNA damage (Humphrey et al, 2008). 
High chain long fatty acids (FA) plasma concentration is also a common link between 
periodontitis, diabetes and cardiovascular risk. FA plasma concentrations are elevated in 
periodontitis (Ramirez-Tortosa et al, 2010) as they are in diabetes (Liu et al, 2010). Both 
elevations can together bring up a very high plasma fatty acids concentration. Normally, 
heart uses fatty acids as energy source generated by ǃ-oxidation and also uses glucose in a 
lesser amount. This high plasma fatty acid concentration will force the heart to use almost 
only free fatty acids as substrate for energy production. Fatty acids get into the cell by 
passive diffusion (20% of fatty acids) and by active transport mediated by CD36 transporter 
(80% of fatty acids). Once inside the cell, fatty acids bind to a cytosolic fatty acid-binding 
protein and are transported to the outer mitochondrial membrane. There, fatty acids are 
sterified and get inside the mitochondrial matrix, where ǃ-oxidation is performed. When the 
FA concentration is excessive, glycolytic intermediates and intracellular lipids accumulate 
because mitochondria are unable to ǃ-oxidate all the FA. This FA excess will produce ROS 
inside the cardiomyocyte cytoplasm as a result of an increased FA oxidation. There will also 
be accumulation of DAG and ceramides. ROS and DAG will activate JNK, IKK kinases and 
PKC respectively. Together, they will downregulate insulin action through serine 
phosphorilation of insulin receptor substrate-1 (IRS-1), what will inactivate IRS-1 and stop 
the insulin pathway. Also, ceramides will inhibit Akt, what will also neutralize insulin 
action. It is still unknown why, but diabetes leads to heart hypertrophy and failure 
independently of atherosclerosis or hypertension. Experiments with rodents that lacked 
CD36 transporter showed that those rodents did not have any cardiac dysfunction. This 
could mean that an excessive FA intake and intramyocardial should be involved in cardiac 
failure somehow. A possible reason is the generation of ROS inside cardiomyocytes.  
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As it is known, ROS can activate NF-κǃ with its consequent production of growth factors 
and pro inflammatory cytokines. ROS can also activate matrix metalloproteinases that have 
the capacity of remodeling the extracellular matrix and cleave sarcomeric proteins such as 
troponin-1 and myosin light chains-1 (MLC-1) what will cause deficiencies in heart 
contractility and even apoptosis if damage is too high. As important is the role of heart 
mitochondria in this process. ROS are able to damage mitochondria and make it produce 
even more ROS and loss of functionality. Damage to mitochondria will release pro apoptotic 
proteins such as cytochrome c, caspases 3 and 9 that will lead to cell death. If 
mitochrondrion is damaged and there is no apoptosis, loss of function will reduce ǃ-
oxidation rate and make FA accumulate, producing even more ROS and beginning the cycle 
(Dirkx et al, 2011). 
Mitochondria have a key role in cardiac failure and remodeling. ROS generation is increased 
in failing myocardium as demonstrated by measurement of 8-iso-prostaglandin F2ǂ. Heart 
is the main oxygen user in the body so ROS generation rate is higher in heart than in other 
organs. When heart is damaged, heart mitochondria ROS generation is enhanced, being able 
to damage myocytes, although, also NADPH oxidase and xanthine oxidase are able to 
produce ROS in heart and damage myocytes. Mitochondria have their own DNA (mtDNA), 
more susceptible to damage because: 
1. It is less protected than nuclear DNA that possesses histones.  
2. mtDNA is located in the mitochondrial matrix, where ROS production is constant by 
the electron transport chain activity. 
3. mtDNA repair is not so effective as nuclear DNA repair. 
There is also cardiac remodeling by activation of metalloproteinases by ROS. Cardiac 
metalloproteinases activity is increased in failing hearts possibly due to the high ROS 
generation in damaged cardiac tissue. Studies with metalloproteinases inhibitors show that 
inhibition limits early left ventricular dilatation in murine models (Tsutsui et al, 2009). 
Periodontitis and cardiovascular disease
 ROS produced in periodontitis can damage
cardiac tissue.
 ROS can also favour the atheroma plaque
development.
 ROS damage mitochondria. Damaged
mitochondrias produce even more ROS.
 ROS activate matrix metalloproteinases.
 High fatty acid concentrations in periodontitis
produce more ROS.
 ROS activate NF-κβ, producing growth factors
and pro-inflammatory cytokines.
 
Fig. 2. Periodontitis and cardiovascular disease 
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Metalloproteinases functions
 Participate in normal tissue remodelling.
 Regulate cell migration, invasion, proliferation
and apoptosis.
 Regulate branching morphogenesis.
 Participate in angiogenesis.
 Participate in wound healing.
 Regulate extracelular matrix degradation.
   
Fig. 3. Metalloproteinases functions 
Mitochondria and periodontitis are also well related. Bacterial lipopolysaccharide released 
during periodontitis by bacteria is able to damage mitochondria by decreasing mitochondria 
membrane potential, mitochondrial mass, CoQ10, and protein expression. CoQ10 deficiency 
also makes a decrease in complex II + III, III and IV activities. This taken together raises ROS 
production inside the mitochondria. The next step before ROS damage is produced is 
liberation of cytochrome c, procaspase-9, caspase-3 and endonuclease G, resulting in DNA 
degradation and cell death.  
4. Metabolic syndrome 
Metabolic syndrome is a compound of afflictions that comprises hypertension, diabetes and 
dyslipidemia caused by abnormal obesity due to physical inactivity and overeating. According 
to the American Heart Association, metabolic syndrome comprises several risk factors as: 
 Abdominal obesity (excessive fat tissue in and around the abdomen). 
 Atherogenic dyslipidemia (blood fat disorders — high triglycerides, low high density 
lipoprotein (HDL) cholesterol and high low density lipoprotein (LDL) cholesterol — 
that foster plaque buildups in artery walls). 
 Elevated blood pressure. 
 Insulin resistance or glucose intolerance. 
 Prothrombotic state (e.g., high fibrinogen or plasminogen activator inhibitor–1 in the 
blood). 
 Proinflammatory state (e.g., elevated C-reactive protein in the blood). 
Metabolic syndrome is associated with periodontitis as shown on epidemiological studies 
that demonstrate the relationship. In a group of 1315 patients, the prevalence of metabolic 
syndrome was higher in patients with advanced periodontitis (66.7 %) than in those 
periodontally healthy (48.8 %)(Borges et al, 2007). Another study from 13,710 participants in 
the NHANES III (Third National Health and Nutrition Examination Survey) showed a 
direct relationship between periodontitis and the prevalence of metabolic syndrome (37% in 
those with severe periodontitis vs. 18% in those with mild or no periodontitis) (D’Aiuto et 
al, 2008; Bullon et al, 2009). 
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People with the metabolic syndrome are at increased risk of coronary heart disease and 
other diseases related to plaque buildups in artery walls (e.g., stroke and peripheral vascular 
disease) and type II diabetes. 
Abdominal obesity, insulin resistance and hypertension seem to be the most important of 
these risk factors in order to develop a cardiovascular disease. They are also influenced by 
oxidative stress as it will be described later.This syndrome is clinically important because of 
the associated cardiovascular risk accumulation, which exceeds that of the component parts. 
Thus, it is important to elucidate the pathophysiology of metabolic syndrome to prevent the 
development of the associated cardiovascular disease (CVD). 
5. Obesity 
Obesity is a state of fat mass excess. Adipose tissue is formed by adipose cells that store 
lipids and also preadipocites. Adipocites accumulate lipids and grow in number and shape. 
There is also a high number of infiltrating macrophages due to the expression of 
interleukins and a high rate of preadipocites differentiation into macrophages by peroxisome 
proliferator-activated receptor gamma (PPAR-Ǆ) and TNF-ǂ. 
Adipocites release also many other molecules that have influence on other biological 
processes, for example, adiponectin, which favors insulin sensibility, lipid oxidation and has 
vascular protective properties but is downregulated in obesity, or angiotensinogen, that acts 
over blood pressure. This molecule concentration is reduced in metabolic syndrome and in 
diabetes. 
5.1 Obesity, periodontitis and oxidative stress 
Obesity is one of the most important parts of metabolic syndrome. It is known that there is 
systemic chronic inflammation and increased ROS generation in obesity, thus, leading to an 
oxidative stress situation. This is mainly due to the production of TNF-ǂ, IL-6, non-esterified 
fatty acids, angiotensinogen and CRP (Ando & Fujita, 2009). Possible reasons why there is 
an increased ROS production in obesity can be: hyperglycemia, increased muscle activity to 
carry excessive weight, elevated tissue lipid levels, inadequate antioxidant defenses, chronic 
inflammation, endothelial ROS production and hyperleptinemia (D’Aiuto et al, 2008). We 
can see that many of these factors as hyperglycemia, inadequate antioxidant defenses, 
chronic inflammation and endothelial ROS production depends on other pathologies related 
to metabolic syndrome, and can be worsened if these pathologies are in an advance state of 
the disease, as diabetes or atherosclerosis. 
Hyperglycemia and obesity are heavily linked, and therefore, obesity and diabetes. Obesity 
induces insulin resistance, suppress the expression of insulin receptors in fat tissue, causing 
glucose deregulation, hyperglycemia and later, ǃ-cell destruction in pancreas, promoting 
diabetes. Due to the impossibility to catch glucose from cells because of this insulin 
resistance, glucose accumulates in the blood stream, leading to hyperglycemia. This leads to 
3 different pathways that will end with the production of ROS:  
 The first pathway is the polyol pathway where glucose is converted to sorbitol, which 
in excess produces oxidative damage. This pathway includes the participation of 
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nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, that produces 
O2*-, especially in the endothelium. 
 The second pathway is the forming of advanced glycosylation end products (AGE) 
because of the reaction between glucose and proteins, lipids and nucleic acids. This 
AGEs binds to specific cell surface receptors (RAGE) and this promote the production 
of NF-κǃ, which in turn activates PKC, sorbitol and transcription of vascular cell 
adhesion molecule-1 (VCAM-1) and intracellular adhesion molecule-1 (ICAM-1). All 
this molecules activation will raise ROS levels. 
 The third pathway is just the glucose auto-oxidation with the generation of oxidants 
with similar reactivity as OH* and O2*- radicals. 
All this three pathways together with an increased metabolic ROS production in obese 
people, inadequate antioxidant defenses due to an unsuitable diet and continuous 
antioxidant attrition will bring up an oxidative stress situation. 
5.2 Obesity, periodontitis and fatty acids 
It is important to talk about the lipid profile and changes in lipid peroxidation with ROS 
production in obesity because it could be linked with periodontitis and cardiovascular risk 
as Ramirez-Tortosa et al.(2010) found in one of their studies. Fat storage, excessive blood 
lipids and dyslipidemia are found in obesity with an increase in plasma saturated, 
monounsaturated and polyunsaturated fatty acids. Periodontitis is a systemic inflammation 
and ROS generator, what will contribute to the oxidation of LDL that are also elevated in 
obesity. 
Dietary intake of lipids can also modify plasma lipid profile as people with high intake of 
saturated and n-6 polyunsaturated fatty acids, but not those with a higher intake of n-3 
polyunsaturated fatty acids, have increased cardiovascular risk due to an increased oxidized 
lipoproteins and vascular inflammation. Total n-3 polyunsaturated fatty acids were 
associated with lower levels of pro inflammatory markers (IL-6, TNF-ǂ, CRP), higher levels 
of anti-inflammatory markers (soluble IL-6r, IL-10, TGF-ǂ) and lower levels of some markers 
of endothelial activation (sVCAM-1 and sICAM-1). This means that n-3 polyunsaturated 
fatty acids are cardio protective, but in periodontitis patients, n-6 polyunsaturated and 
saturated fatty acids predominate in plasma, a proatherogenic lipid profile that is 
responsible for the production of high levels of pro inflammatory TNF-ǂ and 
proatherogenic sVCAM-1 and oxidized LDL (Ramirez-Tortosa et al, 2010). 
There are many ways in which lipids can contribute to oxidative stress as uncoupling of 
mitochondria, susceptibility to ROS attack and production of PKC that also raise glucose 
levels. Also NADPH oxidase activity is increased in adipose tissue and there is a reduced 
activity of antioxidant enzymes as superoxide dismutase (SOD). All these reactions generate 
ROS, leading to lipid and protein oxidation and finally to oxidative stress. 
As seen on this study, there are several changes in the lipid profile in common between 
periodontitis and obesity. These changes were in cholesterol, triacylglycerols, LDL, and very 
low density lipoproteins (VLDL) plasma levels that increased both in periodontitis groups 
as shown in this study and in obesity patients while HDL levels were decreased. As 
periodontitis and obesity are two diseases that share in common general systemic low grade 
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inflammation, IL-6 is elevated in both diseases. One of IL-6 effects is to decrease lipoprotein 
lipase activity, a key enzyme involved in triglycerides catabolism and formation of adipose 
tissue. Reduction in its activity will produce hypertriglyceridemia (Monteiro et al, 2009). 
While ROS have adverse effects on obesity development, and its production is increased in 
obesity, periodontitis ROS production may increment drastically ROS levels, worsening the 
oxidative stress situation in obese patients with periodontitis. Lots of studies link the 
relationship between obesity and oxidative stress (Vincent & Taylor, 2006) by measuring 
lipid peroxidation biomarkers as malondialdehyde (MDA), thiobarbituric reactive acid 
substances (TBARS), C reactive protein (CRP), lipid hydroperoxides, conjugated dienes, 4-
hidroxynonenal (4HNE) and F2isoprostanes (8-epiPGF2ǂ).Those studies showed an increase 
in these biomarker levels in obese patients and also a decrease in antioxidant enzymes, 
showing that there is an increased oxidative stress in this situation. Plasma MDA levels are 
increased in obese patients and it is involved in systemic oxidative stress and in impairment 
of normal glucose metabolism in obese people, which will also contribute to the instauration 
of diabetes, another important risk factor in metabolic syndrome for the development of 
cardiovascular diseases. But not also MDA levels are increased in obesity. All the other 
obesity biomarkers mentioned above were increased. 
Obesity and periodontitis
 Obesity leads to hyperglycemia what will
lead to ROS production.
 There is an increased metabolic rate that
produces high ROS levels.
 LDL and fatty acids are incremented both in
obesity and periodontitis.
 There is a higher NADPH oxidase activity in
obesity.
 Obesity and periodontitis ROS production
together can cause an oxidative stress
situation
 
Fig. 4. Obesity and periodontitis 
It is evident the relation between the plasma lipid profile and the risk of developing 
atherogenesis. Specially, a high LDL concentration may lead to the development of the 
atherogenic plaque and subsequently raise the level of risk of suffering cardiovascular 
diseases. Now, there are evidences of an increase in these levels of plasma LDL in 
periodontitis (Ramirez-Tortosa et al, 2010). If we sum up this phenomenon with the rise of 
plasma LDL happening in obesity, we probably will have a high rise in plasma oxidized 
LDL and therefore a higher risk in developing atheroma plaque. 
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Another factor that promotes oxidative stress situations in obesity is the level of plasma 
leptin. Leptin is a polypeptide hormone that regulates food intake acting on hypothalamic 
centers. It is produced by adipose tissue. It is a cardiovascular risk factor in obese people. 
Leptin is chemically similar to IL-6 cytokine family and so it has pro inflammatory 
properties stimulating the proliferation of monocytes and macrophages and inflammatory 
cytokines. So, indirectly, it stimulates NADPH oxidase activity. It also stimulates directly 
H2O2 and OH* and reduces the activity of paranoxase (PON-1), and antioxidant enzyme and 
this reduction increases urinary and plasma 8-isoprostane and plasma MDA and 
hydroperoxides. Because PON-1 is involved in preventing the accumulation of peroxides in 
LDL, reduction in the activity of this enzyme could contribute to CAD development. 
 
Obesity TNF-α, IL-6, FA, angiotensinogen, LDL, CRP
oxLDL ROSAtherogenesis
n-6 PUFAsVCAM-1, TNF-α
Insulin
resistance
Hyperglycemia
Diabetes
NADPH oxidase, AGEs, glucose autooxidation
ROS NF-κβ
Obesity, periodontitis and ROS
Periodontitis
ROS
1
2
3
4
 
Fig. 5. Obesity, periodontitis and ROS. 1). Obesity is able to produce insulin resistance that 
will lead to hyperglycemia and diabetes. This hyperglycemia rises NADPH oxidase activity, 
favors the formation of AGEs and provoke glucose autooxidation. These three processes will 
generate ROS. 2). There is also a ROS generation by obesity due to a higher metabolism in 
obesity that will sum up to the produced by hyperglycemia. 3). There is an increased LDL 
and angiotensinogen plasma concentration in obesity that will support the formation of the 
atheroma plaque. 4). In addition, periodontitis is able to produce even more ROS to the 
organism, worsening the situation and leading to an oxidative stress status. 
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The last cardiovascular risk factor that obesity can modify is the endothelial function. Obese 
people also suffer from hypertension. Vascular endothelium presents some ROS sources that 
are deregulated in obesity because of the imbalance in rennin-angiotensin system as we saw 
before. Angiotensinogen converts to angiotensin II, leading to NADPH oxidase activity and 
xanthine oxidoreductase activity increase, LDL uptake by macrophages, nitric oxide 
synthase enzymatic uncoupling and the consequent formation of ROS, antioxidant 
depletion, lipid peroxidation and oxidative stress situation (Vicent & Taylor, 2006). Obesity 
is a risk factor for the development of glucose resistance, hypertension, diabetes, possibly 
due to the production of ROS and high plasma lipid levels. 
6. Insulin resistance, glucose impairment, diabetes and periodontitis 
Diabetes mellitus is a syndrome where carbohydrates, lipids and proteins metabolism is 
altered due to a lack of insulin secretion or to a decrease in tissues response to insulin. There 
are two kinds of diabetes: 
 Diabetes mellitus type I: also called insulin dependent diabetes mellitus. In this 
diabetes, there is no production of insulin by pancreas. 
 Diabetes mellitus type II: also called no insulin dependent diabetes mellitus. This 
diabetes presents a decrease in tissues response to insulin called insulin resistance. 
The consequences of diabetes is that every cell, except encephalic cells, will not be able to 
properly use insulin, so plasma glucose levels raise and appears hyperglycemia. 
Type II diabetes is strongly related to obesity. Almost every obese develop type II diabetes. 
The link between obesity and diabetes was unclear till the recent theory of ROS. As we saw 
before, obesity is an important factor in the development of diabetes because of the release 
of pro inflammatory cytokines and production of ROS that lead to an oxidative stress 
situation and the insulin resistance situation in obesity. 
People with diabetes are at high risk of developing other health problems as 
macroangiopathies and microangiopathies. The first one consists on an accelerated 
atheromatosis that will have damaging effects over cardiovascular health. Microangiopathies 
affects to retina, kidney and peripheral nerves. Affliction of the kidney is an important fact in 
the instauration of a renal failure and diabetes is the first cause of chronic renal insufficiency. 
So, diabetes can cause accelerated atheromatosis with hypertension and chronic renal 
insufficiency, leaving the patient to a high cardiovascular disease risk situation. 
Hyperglycemia produce decreased activity of vasodilators such as nitric oxide (NO), 
increased activity of angiotensin II, endothelin-1 and favors the production of permeability 
factors as vascular endothelial growth factor (VEGF). Later on, there is microvascular cell 
loss and capillary occlusion due to extracellular matrix overproduction by action of growth 
factors such as TGF-ǃ and to deposition of extravasated acid-Schiff-positive plasma proteins. 
With respect to hypertension, these changes will produce glomerulosclerosis in the kidney, 
which will cause renal malfunction leading to hypertension. 
Insulin resistance and hyperglycemia also provokes changes in blood lipid profile. 
Cholesterol enriched apolipoprotein B containing remnant particles levels, which is 
proatherogenic, is elevated in diabetes. 
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In diabetes, endothelial cells produce an excess of AGEs. Intracellular hyperglycemia 
originates autooxidation of glucose that ends with the formation of dicarbonyls that reacts 
with amino groups of intracellular and extracellular proteins to form AGEs. This AGEs 
importance keeps on the fact that, inter alia, they are able to react with macrophages and 
mesangial cells AGE receptors and to produce intracellular ROS that activates NF-κǃ 
pathway with its consequent production of growth factors and pro inflammatory cytokines. 
AGE can also be formed on collagen to form very stable collagen macromolecules, resistant 
to normal enzymatic degradation. This AGE-modified collagen accumulates in the walls of 
blood vessels, narrowing the lumen. It also has affinity for LDL, so, AGE-modified collagen 
scavenges LDL and deposits them in the blood vessels walls, contributing to the formation 
of atheroma plaque and further cardiovascular problems. AGE-modified collagen has been 
shown to be found also in periodontal blood vessels. 
AGE also promote the formation of VEGF that induces neovascularization and plays a major 
role in microvascular diabetes complications (Mealey & Oates, 2006). Another important 
molecule upregulated in diabetes is protein kinase C (PKC). This enzyme is activated by 
diacylglycerol, which levels are elevated in diabetes. PKC has several functions: 
 Decrease eNOS activity and increase endothelin-1 activity, producing blood flow 
abnormalities. 
 Increase VEGF levels, promoting vascular permeability and angiongenesis. 
 Induce expression of TGF-ǃ which promotes capillary occlusion. 
 Induce overexpression of the fibrinolytic inhibitor PAI-1. By doing this, vascular 
occlusion is promoted. 
 Activates NF-κǃ pathway, releasing pro inflammatory cytokines. 
 Activate NADPH oxidases that release ROS, leading to multiple effects in the organism. 
Together with the formation of AGE and activation of PKC, in diabetes there is an increased 
flux in the polyol pathway and in the hexosamine pathway, both of them contributes to the 
progression of diabetes. But these four processes link together in a common pathway, the 
overproduction of superoxide by mitochondrial electron transport chain. 
There is a value in the inner mitochondrial membrane proton gradient that when exceeded, 
superoxide production is highly increased. This limit is reached in diabetes, because of the 
overproduction of electron donors by the tricarboxilic acid cycle due to hyperglycemia. This 
is shown by measures of ROS that are elevated in mitochondria in diabetic patients. 
Overexpression of manganese superoxide dismutase (MnSOD) lowered these ROS levels 
and also lowered all the four factors that contribute to diabetes progression: formation of 
AGE, PCK, increased flux in polyol pathway and in hexosamine pathway. By inhibiting 
mitochondrial superoxide production, activation of NF-κǃ is also inhibited. But not only 
MnSOD inhibits these processes, it also suppresses the increase in collagen synthesis in 
mesangial cells, decreases hyperglycemia induced apoptosis in dorsal root ganglion 
neurons, blocks hyperglycemia induced monocyte adhesion, prevents the inhibition of the 
anti atherogenic prostacyclin synthetase, PPAR-Ǆ and endothelial nitric oxide synthase 
(eNOS). 
This gives us an idea of how important is mitochondrial superoxide production and 
mitochondrial integrity in the development and progression of this disease. All damage 
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done to mitochondria could affect its standard ROS production and transform the 
mitochondria in a potent ROS generator. This will not only affect progression of diabetes but 
also obesity, inflammation, hypertension, periodontitis, generating an oxidative stress 
situation (Brownlee, 2001). 
6.1 Diabetes, periodontitis and oxidative stress 
Diabetes and periodontitis are strongly related diseases. People suffering from diabetes 
have higher risk of developing periodontitis and people suffering from periodontitis have 
higher risk of developing diabetes. It is a positive feedback. Treatment of periodontal 
disease improves some diabetes complications as hyperglycemia or glycated hemoglobin. 
The way diabetes affects periodontitis may be as the result of the above mentioned 
processes that leads to release of pro inflammatory cytokines, activation of PKC that 
activates NADPH oxidase, accumulation of AGEs and deficiencies in tissue healing in 
diabetes. This would ease the damage produced in the periodontium and is associated 
with chronic periodontitis. Hyperglycemia produces inhibition of osteoblastic cell 
proliferation and collagen production so bone regeneration is attenuated and damage 
produced in the periodontium is this way higher, having mechanical diminished bone 
properties in the new formed teeth. 
Studies have shown that specially TNF-ǂ, IL-6 and IL-1ǃ are markedly elevated in diabetes. 
Macrophages from diabetic patients release more TNF-ǂ, PKC and O2- than macrophages 
from healthy patients (Karima et al, 2005), possibly due to a high glucose level and oxidative 
stress. Both diseases, periodontitis and diabetes are able to activate an immune host 
response with release of pro inflammatory cytokines and instauration of an oxidative stress 
situation. When both join together in the same patient, they can act synergistically (Nassar et 
al, 2007). 
ROS can also be a final step in which some pathways converge to produce insulin resistance. 
It has been shown that TNF-ǂ and dexamethasone are able to produce ROS. Although TNF-
ǂ is pro inflammatory and dexamethasone is an anti-inflammatory agent, both raise ROS 
levels and produce insulin resistance. Treatment with antioxidant molecules is able to 
decrease insulin resistance, measured as the defect in insulin mediated glucose uptake. Also, 
transgenic models of cell lines genetically modified to overexpress antioxidant enzymes and 
transgenic obese mice treated with antioxidants prevented insulin resistance after treatment 
with TNF-ǂ and dexamethasone. This is indicative of the involvement of ROS in insulin 
resistance as antioxidant agents can prevent this process. Other evidences of ROS implicated 
in insulin resistance are the fact that in obesity, ROS are increased due to a constant 
inflammatory state, and this produce insulin resistance leading to diabetes. Also adipocytes 
treated with high doses of H2O2 or ROS inducers produce insulin resistance. The possible 
mechanism of ROS affecting insulin resistance can depend on the magnitude of ROS 
production, cell type affected, time of exposure, specific type of ROS or other factors that 
will activate any of the involved pathways as FoxO, MAPK, JAK/STAT, p53, phospholipase 
C, PI(3)K and other proteins encoded genes. A possible way is through activation of JNK by 
TNF-ǂ. Antioxidant treatment reduces JNK insulin resistance mediated activity (Houstin et 
al, 2006). This could be the reason of how periodontitis could affect or worsen insulin 
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resistance, by production of ROS that in the long term will produce diabetes as similarly 
happens in obesity. In periodontitis patients with type II diabetes, there is an increased C 
reactive protein level, which means there is increased IL-6 concentration that could 
exacerbate insulin resistance and contribute to diabetes worsening (Aspriello et al, 2011; 
Gomes-Filho et al, 2011).  
It is important to have a good control of these diseases, preventing and if necessary, treating 
them. This is because as the worst the control of diabetes is the worst the effects on 
periodontitis severity and ROS production will be (Tsai et al, 2002; Lalla & Papapanou, 
2011). As higher glycemic status, higher activity of PKC, NADPH oxidase and levels of 
DAG. DAG increases with hyperglycemia through the glycolytic /glycerol-3-phosphate 
acyltransferase pathway. This increase in DAG triggers activation of PKC. Also IL-1ǃ levels 
are double in patients with poor glycemic control (>8 % glycohemoglobin test HbA1c) than 
in patients with good glycemic control. Periodontal treatment is able to reduce systemic 
inflammation, reduce serum TNF-ǂ, C-reactive protein, IL-6, fibrinogen concentration, 
improves HbA1c levels and raise adiponectin concentration (Lalla and Papapanou, 2011). 
Disease control consists on medication, healthy lifestyle and weight control for diabetes and 
proper oral hygiene for periodontitis. Avoid smoking for both diseases. It has been 
demonstrated that clinically treating periodontitis can reduce up to 48 % IL-6 levels in 
patients with periodontitis and type II diabetes (Tamaki et al, 2010) and also can reduce CRP 
levels (Marcaccini et al, 2009). 
Diabetes is strongly related with hypertension and thus, cardiovascular disease. As 
mentioned above, one of the major complications of diabetes is the apparition of 
macroangiopathies and microangiopathies. These processes are favored by AGE products 
formed as a result of hyperglycemia and ROS production, protein kinase C and the renin 
angiotensin system activation. 
AGEs products promote microangiopathies as seen by its apoptotic action over mesangial 
cells and the promotion of vascular endothelial growth factor (VEGF) which will contribute 
to glomerular hyperfiltration, an early renal dysfunction. Also, AGEs stimulate the 
production of insulin like growth factor-I, -II, PDGF and TGF-ǃ in mesangial cells, which in 
turn produce type IV collagen, laminin and fibronectin. TGF-ǃ is an important molecule that 
plays an important role in the pathogenesis of glomerulosclerosis and tubulointerstitial 
fibrosis. AGE-RAGE system is also related with the renin angiotensin system because 
angiotensin II produce ROS in renal cells and ROS are causative of AGEs. Then AGEs 
activate mesangial TGF-ǃ-Smad system which activates production of angiotensin II 
(Yamagishi et al, 2011). 
There are several ways for AGEs products to contribute to the development of 
macroangiopathies such as decrease in the elasticity of the vasculature, quenching of NO, 
decreasing vasodilation, increased oxidative stress that impairs NO synthase and produces 
peroxinitrite (ONOO-), increase in plasma LDL or activation of atherosclerosis related genes 
by ROS generation as ICAM-1, VCAM-1, monocyte chemotactic protein-1(MCP-1), 
plasminogen activator inhibitor-1 (PAI-1), tissue factor, VEGF and RAGE. There is also a 
deficient tissue repair situation in diabetes because of a decrease in endothelial progenitor 
cells (EPCs) number, function and mobilization. These cells are capable of differentiate in 
www.intechopen.com
 
Relationship Between Cardiovascular Risk Factors and Periodontal Disease: Current Knowledge 
 
211 
endothelial cells. Deficit in endothelial repair may lead to accelerated atherosclerosis and 
higher risk of suffering from cardiovascular disease (Yamagishi et al, 2011). 
As it has been mentioned before another important molecule with a protective paper against 
the formation of AGEs, is named PPAR-Ǆ. This is a membrane receptor that acts as a 
transcription factor regulating the expression of genes. They participate in regulation of 
vascular tone, inflammation, hypertension, obesity and metabolic syndrome (Oyekan, 2011). 
PPAR-Ǆ reduces blood pressure by reducing the expression of ATII type 1 receptor and 
inhibiting ATII signaling pathways, what will suppress the renin angiotensin system (RAS). 
Regulation of hypertension comes from the suppression of RAS and also of the 
thromboxane A2 system. And by reducing hypertension, renal function is facilitated 
(Sugawara et al, 2010). PPAR-Ǆ agonists could be a powerful tool to improve diabetes 
complications since its activation also inhibit nitrite, fibronectin and type IV collagen 
production by mesangial cells and attenuate AGE induced production of IL-8 and ICAM-1 
in proximal tubular epithelial cells. PPAR-Ǆ agonists also lower TNF-ǂ by suppressing NF-
κǃ activation and downregulate RAGEs expression, what in the end leads to an avoidance of 
the release of ROS, MCP-1 or VCAM-1 (Yamagishi et al, 2011). 
AGEs products are really harmful molecules produced in diabetes that can affect to 
oxidative stress by increasing ROS production and also raise the risk of cardiovascular 
disease by promoting renal failure and atherosclerosis and the develops of periodontitis.  
 
 
Advanced glycation end products (AGEs) functions
 React with macrophages, mesangial cells and 
produce ROS. 
 ROS activate NF-κβ.
 NF-κβ produce cytokines and growth factors
(insulin like growth factor-I, platelet derived growth
factor or TGF-β).
 AGEs forms modified collagen that accumulates in 
blood vessel walls.
 Scavenge LDL and deposit them in blood vessel
walls.
 Promotes angiotensin II production.
 Quenching of NO.
 
 
 
Fig. 6. Advanced glycation end products (AGEs) functions 
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7. Conclusion 
So, to summarize, periodontitis not also affects cardiac health in a direct manner by ROS 
production, but also in an indirect way by promoting the instauration of the metabolic 
syndrome (obesity, insulin resistance, atherogenic dyslipemia, hypertension, pro- 
inflammatory state and prothrombotic state). Even so, the common link between 
periodontitis and metabolic syndrome or cardiovascular disease is also the action of ROS 
either acting as a second messenger or directly damaging target molecules as proteins, lipids 
or DNA. We have seen that periodontitis is a process that generates a great amount of ROS, 
not only in the site of the infection, the periodontium, but also releases pro-inflammatory 
cytokines and ROS to the rest of the organism, leading to an oxidative stress situation and a 
depletion of anti-oxidant molecules over time. This will also contribute to aggravate any 
other illness that could be already present at the patient or simply help them to arise as any 
of the metabolic syndrome components. In fact, ROS are seen to participate in lots of organic 
processes and could be the reason of the instauration of certain afflictions as insulin 
resistance, hypertension or atheroma plaque development. ROS and oxidative stress are 
always present at every one of these illnesses that lead to cardiovascular disease, and they 
even participate directly in cardiovascular damage.  
In obesity, hyperglycemia is able to produce ROS by 3 different ways as we saw before: 
AGEs formation and NF-κǃ activation, conversion of glucose to sorbitol and activation of 
NADPH oxidase and glucose auto-oxidation. There is also a major metabolic rate in obese 
people and more NADPH oxidase activity that will produce more ROS than non-obese 
people. And this higher ROS generation together with the high plasma LDL and free fatty 
acids levels is able to damage the endothelium by promoting the formation of the atheroma 
plaque and lipid peroxidation. 
In diabetes, AGEs formation produces ROS as in obesity. There is an increased flux in the 
polyol pathway that produces ROS. Also, diabetic macrophages release more TNF-ǂ, IL-6 
and IL-ǃ, what will produce even more ROS. If this is not enough, in diabetes, angiotensin II 
levels are higher, and we have seen that it is able to produce ROS by stimulation of NADP 
oxidase.  
In hypertension, angiotensin II, endothelin-1 and urotensin II levels are higher, so, they will 
stimulate NADPH oxidase with its consequents effects over ROS production. These ROS 
will also uncouple NO synthase and react with NO to form ONOO-. In a hypertensive 
situation, mitochondria activity is elevated, and therefore, ROS generation will be higher, 
having higher risk for mitochondrial damage. ROS are also able to produce 
glomerulopathies and to oxidize LDL thus promoting the formation of atheroma plaque. 
Finally, ROS can damage by themselves cardiomyocytes directly, leading to heart 
malfunction. They also activate matrix metalloproteinases that will remodel coronary blood 
vessels and arteries, leading to coronary insufficiency. As in hypertension, mitochondrion is 
also compromised by ROS action, with risk of releasing pro apoptotic molecules that will 
undergo cardiomyocyte apoptosis. Cardiomyocytes regeneration rate is scarce or even null, 
so cardiomyocyte loss is a very important event in heart damage and cardiovascular 
development. 
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All these processes implicate ROS production and an oxidative stress situation installed in 
the organism. We have seen that ROS are involved in lots of damaging mechanisms and 
they can ease the emergence of some of these afflictions that compromises cardiovascular 
health. Periodontitis, as a high ROS and pro inflammatory generator process can greatly 
contribute to aggravate all of these symptoms. It is not involved in cardiovascular failure by 
itself directly, but in an indirect manner, it can worsen the harmful effects exerted by 
metabolic syndrome. As we have seen, periodontal treatments decreased ROS generation 
and the risk of developing some of these illnesses. As these illnesses are risk factors for 
developing cardiovascular diseases, avoiding periodontitis also lowers the probability of 
developing these cardiovascular risk factors. This is a good trail that takes us to believe on 
the relationship between periodontitis and cardiovascular disease. 
8. References 
Ando K, Fujita T. (2009). Metabolic syndrome and oxidative stress. Free Radic Biol Med.  1; 47 
(3): 213-8. 
Aspriello SD, Zizzi A, Tirabassi G, Buldreghini E, Biscotti T, Faloia E, Stramazzotti D, 
Boscaro M, Piemontese M. (2011).Diabetes mellitus-associated periodontitis: 
differences between type 1 and type 2 diabetes mellitus. J Periodontal Res. 46(2): 
164-9. 
Baelum V, Lopez R. (2004). Periodontal epidemiology: towards social science or molecular 
biology?. Community Dent Oral Epidemiol.  32 (4): 239-49. 
Borges I Jr, Moreira EA, Filho DW, de Oliveira TB, da Silva MB, Fröde TS. (2007). 
Proinflammatory and Oxidative Stress Markers in Patients with Periodontal 
Disease. Mediators Inflamm.  2007: 45794. 
Borges PK, Gimeno SG, Tomita NE, Ferreira SR (2007). Prevalence and characteristics 
associated with metabolic syndrome in Japanese- Brazilians with and without 
periodontal disease. Cad Saude Publica. 23;657-668. 
Brecx M, Frolicher I, Gehr P, Lang NP. (1998). Stereological observations on long term 
experimental gingivitis in man. J ClinPeriodontol  15: (621–627). 
Brownlee M. (2001). Biochemistry and molecular cell biology of diabetic complications. 
Nature.  13; 414(6865): 813-20. 
Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN, Battino M. (2009). 
Metabolic syndrome and periodontitis: is oxidative stress a common link?. J Dent 
Res. 88:503–18. 
Bullon P, Cordero M, Quiles JL, Morillo JM, Ramirez-Tortosa MC, Battino M. (2011). 
Mitochondrial dysfunction promoted by Porphyromonas gingivalis 
lipolysaccharide as a possible link between cardiovascular disease and 
periodontitis.  Free Radical in Medicine & Biology, in press. 
Chang JC, Kou SJ, Lin WT, Liu CS. (2010). Regulatory role of mitochondria in oxidative 
stress and atherosclerosis. World J Cardiol.  26; 2 (6): 150-9.  
D’Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield J, et al. (2008). 
Association of the metabolic syndrome with severe periodontitis in a large U.S. 
population-based survey. J Clin Endocrin Metab. 93;3989-3994. 
www.intechopen.com
 
Cardiovascular Risk Factors 
 
214 
D'Aiuto F, Nibali L, Parkar M, Patel K, Suvan J, Donos N. (2010). Oxidative Stress, Systemic 
Inflammation, and Severe Periodontitis. J Dent Res.  89 (11): 1241-6. 
Dirkx E, Schwenk RW, Glatz JF, Luiken JJ, van Eys GJ. (2011). High fat diet induced diabetic 
cardiomyopathy. Prostaglandins Leukot Essent Fatty Acids. May 13. [Epub ahead of 
print] PMID: 21571515 [PubMed - as supplied by publisher]  
Ekuni D, Endo Y, Irie K, Azuma T, Tamaki N, Tomofuji T, Morita M. (2010).  Imbalance of 
oxidative/anti-oxidative status induced by periodontitis is involved in apoptosis of 
rat submandibular glands. Arch Oral Biol. 55 (2): 170-6. 
Fialkow L, Wang Y, Downey GP. (2007). Reactive oxygen and nitrogen species as 
signaling molecules regulating neutrophil function. Free RadicBiol Med.  15; 42 (2): 
153-64. 
Fitzgerald DC, Meade KG, McEvoy AN, Lillis L, Murphy EP, MacHugh DE, Baird AW. 
(2007). Tumour necrosis factor-ǂ (TNF-ǂ) increases nuclear factor κB (NFκB) 
activity in and interleukin-8 (IL-8) release from bovine mammary epithelial cells. 
Vet Immunol Immunopathol. 15; 116 (1-2): 59-68.  
Gomes-Filho IS, Freitas Coelho JM, Seixas da Cruz S, Passos JS, Teixeira de Freitas CO, 
AragãoFarias NS, Amorim da Silva R, Silva Pereira MN, Lima TL, Barreto ML. 
(2011). Chronic Periodontitis and C-reactive Protein Levels.J Periodontol. 82 (7): 969-
78. 
Houstis N, Rosen ED, Lander ES. (2006). Reactive oxygen species have a causal role in 
multiple forms of insulin resistance. Nature.  13; 440 (7086): 944-8. 
Humphrey LL, Fu R, Buckley DI, Freeman M, Helfand M. (2008). Periodontal disease and 
coronary heart disease incidence: a systematic review and meta-analysis. J Gen 
Intern Med.  23 (12): 2079-86. 
Karima M, Kantarci A, Ohira T, Hasturk H, Jones VL, Nam BH, Malabanan A, Trackman 
PC, Badwey JA, Van Dyke TE. (2005).  Enhanced superoxide release and elevated 
protein kinase C activity in neutrophils from diabetic patients: association with 
periodontitis. J Leukoc Biol.  78 (4): 862-70. 
Kinane DF, Mark Bartold P. (2007).  Clinical relevance of the host responses of periodontitis. 
Periodontol 2000.  43: 278-93.  
Kinane DF. (2001). Causation and pathogenesis of periodontal disease. Periodontol 2000.  25: 
8–20. 
Laky M, Assinger A, Esfandeyari A, Bertl K, Haririan H, Volf I. (2011). Decreased 
phosphorylation of platelet vasodilator-stimulated phosphoprotein in 
periodontitis--a role of periodontal pathogens. Thromb Res. 128 (2): 155-60. 
Lalla E, Papapanou PN. (2011). Diabetes mellitus and periodontitis: a tale of two 
common interrelated diseases. Nat Rev Endocrinol. 28. doi: 10.1038/nrendo. 
2011. 106. 
Liu L, Li Y, Guan C, Li K, Wang C, Feng R, Sun C. (2010). Free fatty acid metabolic profile 
and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus 
based on GC-MS and multivariate statistical analysis. J Chromatogr B AnalytTechnol 
Biomed Life Sci.  15; 878 (28): 2817-25. 
Marcaccini AM, Meschiari CA, Sorgi CA, Saraiva MC, de Souza AM, Faccioli LH, Tanus-
Santos JE, Novaes AB, Gerlach RF. (2009).  Circulating interleukin-6 and high-
www.intechopen.com
 
Relationship Between Cardiovascular Risk Factors and Periodontal Disease: Current Knowledge 
 
215 
sensitivity C-reactive protein decrease after periodontal therapy in otherwise 
healthy subjects.  J Periodontol.  80 (4): 594-602. 
Mealey BL, Oates TW. (2006). American Academy of Periodontology. Diabetes Mellitus and 
Periodontal Diseases. J Periodontol.  77 (8): 1289-303.  
Monteiro AM, Jardini MA, Alves S, Giampaoli V, Aubin EC, FigueiredoNeto AM, Gidlund 
M. (2009).  Cardiovascular disease parameters in periodontitis. J Periodontol.  80 (3): 
378-88. 
Nassar H, Kantarci A, van Dyke TE. (2007). Diabetic periodontitis: a model for activated 
innate immunity and impaired resolution of inflammation. Periodontol 2000.  43: 
233-44.  
Oyekan A. (2011). PPARs and their Effects on the Cardiovascular System. Clin Exp 
Hypertens. 33(5):287-93 
Paquette DW, Brodala N, Nichols TC. (2007). Cardiovascular disease, inflammation, and 
periodontal infection. Periodontol 2000.  44: 113-26. 
Papapanagiotou D, Nicu EA, Bizzarro S, Gerdes VE, Meijers JC, Nieuwland R, van der 
Velden U, Loos BG. (2009). Periodontitis is associated with platelet activation. 
Atherosclerosis. 202 (2): 605-11 
Paraskevas S, Huizinga JD, Loos BG. (2008). A systematic review and meta-analyses on C-
reactive protein in relation to periodontitis. J Clin Periodontol. 35 (4): 277-90. 
Ramirez-Tortosa MC, Quiles JL, Battino M, Granados S, Morillo JM, Bompadre S, Newman 
HN, Bullon P. (2010).Periodontitis is associated with altered plasma fatty acids and 
cardiovascular risk markers. Nutr Metab Cardiovasc Dis. 20 (2): 133-9. 
Sugawara A, Uruno A, Kudo M, Matsuda K, Yang CW, Ito S. (2010).Effects of PPARǄ  
on hypertension, atherosclerosis, and chronic kidney disease. Endocr J. 57 (10): 
847-52. 
Sutherland WH, de Jong SA, Walker RJ, et al. (2002). Effect of meals rich in heated olive and 
safflower oils on oxidation of postprandial serum in healthy men. Atherosclerosis 
160(1):195–203. 
Tamaki N, Tomofuji T, Ekuni D, Yamanaka R, Morita M. (2010). Periodontal treatment 
decreases plasma oxidized LDL level and oxidative stress. Clin Oral Investig. 18 
Aug 18. 
Tonetti MS. (2009). Periodontitis and risk for atherosclerosis: an update on intervention 
trials. J ClinPeriodontol.  36; 10: 15-9. 
Tsai C, Hayes C, Taylor GW. (2002). Glycemic control of type 2 diabetes and severe 
periodontal disease in the US adult population. Community Dent Oral Epidemiol.  30 
(3): 182-92. 
Tsutsui H, Kinugawa S, Matsushima S. (2009). Mitochondrial oxidative stress and 
dysfunction in myocardial remodelling. Cardiovasc Res. 15; 81 (3): 449-56. 
Vincent HK, Taylor AG. (2006). Biomarkers and potential mechanisms of obesity-induced 
oxidant stress in humans. Int J Obes (Lond).  30 (3): 400-18. 
Yamagishi SI, Maeda S, Matsui T, Ueda S, Fukami K, Okuda S. (2011). Role of advanced 
glycation end products (AGEs) and oxidative stress in vascular complications in 
diabetes. Biochim Biophys Acta.  [Epub ahead of print] PMID: 21440603 
www.intechopen.com
 
Cardiovascular Risk Factors 
 
216 
Zadik Y, Bechor R, Galor S, Levin L. (2010). Periodontal disease might be associated even 
with impaired fasting glucose. Br Dent J 208. (10):E20. 
www.intechopen.com
Cardiovascular Risk Factors
Edited by Prof. Armen Gasparyan
ISBN 978-953-51-0240-3
Hard cover, 498 pages
Publisher InTech
Published online 14, March, 2012
Published in print edition March, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Cardiovascular risk factors contribute to the development of cardiovascular disease from early life. It is thus
crucial to implement preventive strategies addressing the burden of cardiovascular disease as early as
possible. A multidisciplinary approach to the risk estimation and prevention of vascular events should be
adopted at each level of health care, starting from the setting of perinatology. Recent decades have been
marked with major advances in this field, with the emergence of a variety of new inflammatory and immune-
mediated markers of heightened cardiovascular risk in particular. The current book reflects some of the
emerging concepts in cardiovascular pathophysiology and the shifting paradigm of cardiovascular risk
estimation. It comprehensively covers primary and secondary preventive measures targeted at different age
and gender groups. Attention is paid to inflammatory and metabolic markers of vascular damage and to the
assessment of vascular function by noninvasive standardized ultrasound techniques. This is a must-read book
for all health professionals and researchers tackling the issue of cardiovascular burden at individual and
community level. It can also serve as a didactic source for postgraduate medical students.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Sergio Granados-Principal, Nuri El-Azem, Jose L. Quiles, Patricia Perez-Lopez, Adrian Gonzalez and
MCarmen Ramirez-Tortosa (2012). Relationship Between Cardiovascular Risk Factors and Periodontal
Disease: Current Knowledge, Cardiovascular Risk Factors, Prof. Armen Gasparyan (Ed.), ISBN: 978-953-51-
0240-3, InTech, Available from: http://www.intechopen.com/books/cardiovascular-risk-factors/relationship-
between-cardiovascular-risk-factors-and-periodontal-disease-current-knowledge
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
